We signed the Oligonucleotides Therapeutics Discovery Collaboration Agreement with Nissan Chemical Co., Ltd.

We aim to create new oligonucleotide therapeutics based on a new oligonucleotide therapeutics structure by combining the two companies’ oligonucleotide therapeutics drug discovery platform technologies.

Please click here for details.